We're pleased to announce that Chris was recognized specifically for his contributions for COVID-19 biosafety support.

"I am humbled to be named as the recipient of the 2021 ABSA John H. Richardson Special Recognition Award. This award is a nomination by colleagues and peers to recognize an individual for a specific contribution that as enhanced the profession of biosafety in the past year.

Given the challenges of biosafety support towards clinical trials in the time of a pandemic, while I am thrilled to accept this award, I also want to highlight the team at Clinical Biosafety Services and affiliates who succeeded in accomplishing the review of hundreds of sites for biosafety review for different COVID-19 vaccine clinical trials."

-Chris Jenkins

Mission Statement

SABAI Global's Mission is to be considered a "World Renowned Thought Leader" in the IBC and IRB space, facilitating positive change in medicine and in the lives of many people; and maintaining the status of an "Employer of Choice" by demonstrating daily, the value we place on our employees, consultants and partners.